Literature DB >> 16928814

A mitochondrial targeted fusion peptide exhibits remarkable cytotoxicity.

Benedict Law1, Luisa Quinti, Yongdoo Choi, Ralph Weissleder, Ching-Hsuan Tung.   

Abstract

A potent cytotoxic peptide (r7-kla) was synthesized by incorporating a mitochondrial membrane disrupting peptide, kla (klaklakklaklak), with a cell-penetrating domain, r7 (rrrrrrr). The IC(50) of r7-kla (3.54 +/- 0.11 micromol/L) was more than two orders of magnitude lower than that of kla. r7-kla induced cell death in both in vitro and in vivo environments, and showed rapid kinetics. Within minutes, the morphologic changes in cells and mitochondrial leakage were apparent by microscopy and was consistent with rapid apoptosis. Our results suggested that r7-kla is an apoptosis inducer and can be potentially used as an antitumor agent, especially when combined with the appropriate systemic delivery systems.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16928814     DOI: 10.1158/1535-7163.MCT-05-0509

Source DB:  PubMed          Journal:  Mol Cancer Ther        ISSN: 1535-7163            Impact factor:   6.261


  31 in total

Review 1.  The use of therapeutic peptides to target and to kill cancer cells.

Authors:  R J Boohaker; M W Lee; P Vishnubhotla; J M Perez; A R Khaled
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

2.  Functional Peptide Nanofibers with Unique Tumor Targeting and Enzyme-Induced Local Retention Properties.

Authors:  Vanessa Bellat; Richard Ting; Teresa L Southard; Linda Vahdat; Henrik Molina; Joseph Fernandez; Omer Aras; Tracy Stokol; Benedict Law
Journal:  Adv Funct Mater       Date:  2018-09-14       Impact factor: 18.808

3.  Rational development of a cytotoxic peptide to trigger cell death.

Authors:  Rebecca J Boohaker; Ge Zhang; Michael W Lee; Kathleen N Nemec; Santimukul Santra; J Manuel Perez; Annette R Khaled
Journal:  Mol Pharm       Date:  2012-05-29       Impact factor: 4.939

4.  Targeted delivery of a proapoptotic peptide to tumors in vivo.

Authors:  Sandrine Dufort; Lucie Sancey; Amandine Hurbin; Stéphanie Foillard; Didier Boturyn; Pascal Dumy; Jean-Luc Coll
Journal:  J Drug Target       Date:  2010-12-24       Impact factor: 5.121

Review 5.  Cell penetrating peptides: intracellular pathways and pharmaceutical perspectives.

Authors:  Leena N Patel; Jennica L Zaro; Wei-Chiang Shen
Journal:  Pharm Res       Date:  2007-04-19       Impact factor: 4.200

Review 6.  Studies on anticancer activities of antimicrobial peptides.

Authors:  David W Hoskin; Ayyalusamy Ramamoorthy
Journal:  Biochim Biophys Acta       Date:  2007-11-22

7.  Systemic Delivery of Tumor-Targeted Bax-Derived Membrane-Active Peptides for the Treatment of Melanoma Tumors in a Humanized SCID Mouse Model.

Authors:  Anastassia Karageorgis; Michaël Claron; Romain Jugé; Caroline Aspord; Fabien Thoreau; Claire Leloup; Jérôme Kucharczak; Joël Plumas; Maxime Henry; Amandine Hurbin; Pascal Verdié; Jean Martinez; Gilles Subra; Pascal Dumy; Didier Boturyn; Abdel Aouacheria; Jean-Luc Coll
Journal:  Mol Ther       Date:  2017-02-01       Impact factor: 11.454

8.  Glycosylated cell-penetrating peptides and their conjugates to a proapoptotic peptide: preparation by click chemistry and cell viability studies.

Authors:  Laurence Dutot; Pascaline Lécorché; Fabienne Burlina; Rodrigue Marquant; Vanessa Point; Sandrine Sagan; Gérard Chassaing; Jean-Maurice Mallet; Solange Lavielle
Journal:  J Chem Biol       Date:  2009-11-10

9.  Chondroitin sulfate as a molecular portal that preferentially mediates the apoptotic killing of tumor cells by penetratin-directed mitochondria-disrupting peptides.

Authors:  Hao Yang; Shan Liu; Huawei Cai; Lin Wan; Shengfu Li; Youping Li; Jingqiu Cheng; Xiaofeng Lu
Journal:  J Biol Chem       Date:  2010-05-18       Impact factor: 5.157

10.  Versatile Nanodelivery Platform to Maximize siRNA Combination Therapy.

Authors:  Seung Koo Lee; Benedict Law; Ching-Hsuan Tung
Journal:  Macromol Biosci       Date:  2016-09-22       Impact factor: 4.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.